Olorinab Uses, Dosage, Side Effects and more
Olorinab is under investigation in clinical trial NCT03155945 (Tolerability, Pharmacokinetics, and Efficacy of APD371 in Subjects With Crohn's Disease Experiencing Abdominal Pain).
| Attribute | Details |
|---|---|
| Trade Name | Olorinab |
| Generic | Olorinab |
| Olorinab Other Names | Olorinab |
| Type | |
| Formula | C18H23N5O3 |
| Weight | Average: 357.414 Monoisotopic: 357.180089621 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
